PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.66%
Negative revenue growth while 3141.T stands at 3.87%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.38%
Negative gross profit growth while 3141.T is at 7.63%. Joel Greenblatt would examine cost competitiveness or demand decline.
-15.27%
Negative EBIT growth while 3141.T is at 37.60%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-23.77%
Negative operating income growth while 3141.T is at 42.64%. Joel Greenblatt would press for urgent turnaround measures.
-15.66%
Negative net income growth while 3141.T stands at 37.28%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.66%
Negative EPS growth while 3141.T is at 37.23%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.66%
Negative diluted EPS growth while 3141.T is at 37.36%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
74.19%
10Y revenue/share CAGR at 50-75% of 3141.T's 106.57%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
66.93%
5Y revenue/share CAGR 1.25-1.5x 3141.T's 56.96%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
36.33%
3Y revenue/share CAGR at 75-90% of 3141.T's 45.21%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
197.70%
Below 50% of 3141.T's 655.68%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
61.57%
Below 50% of 3141.T's 129.74%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
48.90%
3Y net income/share CAGR 50-75% of 3141.T's 81.83%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
222.31%
10Y equity/share CAGR in line with 3141.T's 214.77%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
133.90%
5Y equity/share CAGR 1.25-1.5x 3141.T's 103.08%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
65.83%
3Y equity/share CAGR 1.25-1.5x 3141.T's 50.23%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
-10.00%
Negative 5Y dividend/share CAGR while 3141.T stands at 180.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
50.00%
Below 50% of 3141.T's 110.00%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
147.76%
AR growth well above 3141.T's 0.46%. Michael Burry fears inflated revenue or higher default risk in the near future.
8.38%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.02%
Asset growth at 50-75% of 3141.T's 1.40%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.65%
75-90% of 3141.T's 4.46%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-7.61%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
1.36%
SG&A declining or stable vs. 3141.T's 3.26%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.